I don't know. Maybe the OP knows the answer to that question. As I said I prefer to reference IFRA.
I agree and never suggested otherwise.
Of course not, and to my recollection I have not suggested that you do. What I said was that for me, I choose to avoid EOs that are contraindicated for certain groups (pregnant women, children) in products for those groups because for me I feel that is best practice. I am speaking for myself. Personally, I'd rather err on the side of being over cautious than to err on the side of causing damage when it comes to certain groups of people and personal care products.
Perhaps miniscule if used properly and applied to intact skin. Perhaps not if used improperly or applied to damaged skin or mucous membranes. Remember my background is nursing and I have seen lots of non-intact skin and mucous membranes in my career, so I know for a fact that lots of people apply personal care products to less than healthy skin. It happens all the time.
Where 'we' is referencing the authors, correct? Or does he/ or do they refer to the the industry as a whole? Not that it matters, I get the point.
But I would like to point out that EOs are sometime or even frequently used as pharmaceuticals. In our discussion, no they are not, but in some cases they are and in fact in some cosmetics they are, which makes those cosmetics drugs (i.e.; pharmaceuticals), per FDA standards in the US and I believe in some other countries as well.